Summary
- Current Price
- As of today, KRYS price is $276.36, up +1.42% on
- Current Price All-Time High
- KRYS price is currently -7.36% below its historical high of $298.30 set on
- Market Cap
- KRYS current market cap is $8B, up +60.48% over the past 365 days
- PE Ratio
- KRYS current PE ratio is 40.38
- Revenue
- KRYS current annual revenue is $389.13M, up +33.94% year-over-year
- Next Earnings
- The next earnings release for KRYS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Krystal Biotech, Inc. |
| Ticker | NASDAQ: KRYS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | krystalbio.com |
| Employees | 275 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $276.36 | |
| Price, 1D Change | +1.42% | |
| $8B | ||
| - | ||
| 40.38 | ||
| 0.80 | ||
| $389M | ||
| Revenue, 1Y Change | +33.94% | |
| $6.84 | ||
| EPS, 1Y Change | +128.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $6.84 | ||
| EPS Estimate | N/A | $7.82 |
| EPS Est. Change | N/A | +14.33% |
| $389.13M | ||
| Revenue Estimate | N/A | $542.93M |
| Revenue Est. Change | N/A | +39.52% |
| Current Price | $276.36 | |
| Price Target | - | $310.00 |
| Price Tgt. Change | - | +12.17% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.17 | $3.00 | -42.02% | |
| $7.13 | $6.84 | -4.06% | |
| $7.82 | N/A | +14.33% | |
| $10.45 | N/A | +52.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $290.59M | $290.52M | -0.02% | |
| $387.60M | $389.13M | +0.39% | |
| $542.93M | N/A | +39.52% | |
| $692.43M | N/A | +77.94% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $276.36 | |
| $189.69 | ||
| SMA 200 vs Price | -31.36% | |
| $266.11 | ||
| SMA 50 vs Price | -3.71% | |
| 0.80 | ||
| $12.20 | ||
| 53.31 | ||
| 57.09% | ||
| 42.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $389.13M | ||
| $6.84 | ||
| $360.36M | ||
| 92.61% | ||
| $161.30M | ||
| 41.45% | ||
| $204.83M | ||
| 52.64% | ||
| $167.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 9.95 | ||
| 9.56 | ||
| - | ||
| 5 | ||
| 43.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 40.38 | ||
| 20.59 | ||
| 6.57 | ||
| 42.91 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.22B | ||
| $827.79M | ||
| $1.33B | ||
| $1.02B | ||
| $114.23M | ||
| $102.94M | ||
| $9.34M | ||
| $1.77M | ||
| $3.24M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $184.30M | ||
| $199.06M | ||
| $28.77M | ||
| $0.00 | ||
| $6.55M | ||
| $0.00 | ||
| -$15.36M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $200.87M | ||
| -$58.42M | ||
| $8.71M | ||
| $11.95M | ||
| $188.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Chardan Capital | → | |
| Jefferies | → | |
| Goldman Sachs | → | |
| B of A Securities | → | |
| Citigroup | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with KRYS
FAQ
What is the ticker symbol for Krystal Biotech, Inc.?
The ticker symbol for Krystal Biotech, Inc. is NASDAQ:KRYS
Does Krystal Biotech, Inc. pay dividends?
No, Krystal Biotech, Inc. does not pay dividends
What sector is Krystal Biotech, Inc. in?
Krystal Biotech, Inc. is in the Healthcare sector
What industry is Krystal Biotech, Inc. in?
Krystal Biotech, Inc. is in the Biotechnology industry
What country is Krystal Biotech, Inc. based in?
Krystal Biotech, Inc. is headquartered in United States
When did Krystal Biotech, Inc. go public?
Krystal Biotech, Inc. initial public offering (IPO) was on September 20, 2017
Is Krystal Biotech, Inc. in the S&P 500?
No, Krystal Biotech, Inc. is not included in the S&P 500 index
Is Krystal Biotech, Inc. in the NASDAQ 100?
No, Krystal Biotech, Inc. is not included in the NASDAQ 100 index
Is Krystal Biotech, Inc. in the Dow Jones?
No, Krystal Biotech, Inc. is not included in the Dow Jones index
When was Krystal Biotech, Inc. last earnings report?
Krystal Biotech, Inc.'s most recent earnings report was on February 17, 2026
When does Krystal Biotech, Inc. report earnings?
The next expected earnings date for Krystal Biotech, Inc. is May 4, 2026
Data Sources & References
- KRYS Official Website www.krystalbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1711279/000171127926000016/0001711279-26-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1711279/000171127926000016/0001711279-26-000016-index.htm
- KRYS Profile on Yahoo Finance finance.yahoo.com/quote/KRYS
- KRYS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/krys